Back from the grave

It’s been a spooky, spirited season for prescription digital therapeutics (PDTs). Around Halloween, RESET and RESET-O—two PDTs that were laid to rest after their initial developer, Pear Therapeutics, filed for bankruptcycame back to life as part of PursueCare’s virtual treatment offering for substance use disorders sold to health plans. Not long before, Big Health earned FDA clearance for PDTs addressing anxiety and insomnia, while Highmark rebooted PDT coverage in its commercial plans, spurring optimism among developers. With CMS’s 2025 billing codes for behavioral health PDTs now finalized, the cauldron of possibility is brewing—but only time will tell if these programs are back for good, or if they’re dead assets walking.

+ As GLP-1s reshape the healthcare landscape, critical questions are emerging about medication shortages, long-term treatment sustainability, and broader health outcomes. On November 13th at 9am PT / 12pm ET, Rock Health Advisory will host a webinar designed to answer the burning questions of enterprise innovation leaders interested in building, buying, or implementing solutions in the weight care space—register here.

+ Are you a talented, experienced writer with deep expertise in healthcare and technology? Rock Health Advisory is hiring a content writer to support our thought leadership efforts. Learn more and apply here!

Headlines

Oracle Announces New AI-Powered EHR
EHR built from scratch—not from Cerner—touts voice control and AI capabilities CNBC

Nvidia Plans To Provide The Building Blocks Of AI In Health Tech
Supporting health-related AI use cases, on the heels of a partnership to advance AI adoption Endpoints News

Digital Hypertension Solutions: Medication Management Shows Superior Results
PHTI compares “usual care” to three categories of digital hypertension solutions HIT Consultant

Why Your Next Prescription Could Include An App
FDA draft guidance on prescription drug-use related software (PDURS) has players suiting up Axios

State Of Health Tech 2024
The name of the game this year is resilience Bessemer Venture Partners

Bariatric Surgeries Plunge In GLP-1 Era
Studys shows 25.6% decline in surgery for weight care, 132.6% increase in GLP-1 prescriptions Becker’s Hospital Review

Recent Funding

  • CredibleMind picks up $7.5M to expand solutions for mental health and wellbeing
  • Hello Patient launches with $6.3M to develop AI agents to automate patient phone calls
  • Dental staffing marketplace Toothio grabs $5M
  • Ataraxis AI secures $4M to apply multi-modal algorithms to cancer treatment selection